Guizhou Yibai Pharmaceutical's low P/S ratio may be due to p...
Guizhou Yibai Pharmaceutical's low P/S ratio may be due to poor financial performance and declining revenue. The company's downward momentum and medium-term conditions form a barrier for the share price.
The Market Doesn't Like What It Sees From Guizhou Yibai Pharmaceutical Co., Ltd.'s (SHSE:600594) Revenues Yet As Shares Tumble 25%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4088Followers
0Following
9096Visitors
Follow